Community Health Systems INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NYSE
Community Health Systems reported a 9.8% decrease in net operating revenues for Q2 2026, alongside a significant drop in net income, though same-store revenues saw a modest increase.
NYSE
Community Health Systems has finalized the sale of four Arkansas hospitals and associated facilities to Freeman Health System for $110 million.
NYSE
Community Health Systems reported a net loss of $58 million for the first quarter of 2026, citing divestitures and lower patient volumes.
NYSE
Community Health Systems, Inc. completed the sale of Crestwood Medical Center and its associated facilities for $459 million in cash, impacting pro forma financials.
NYSE
Community Health Systems announced a definitive agreement to divest four Arkansas hospitals and related outpatient facilities to Freeman Health System for $112 million.
NYSE
Community Health Systems' Board approved 2026 compensation packages for its key executive officers, including base salaries, cash incentives, and long-term equity awards.
NYSE
Community Health Systems completed the sale of its 80% ownership interest in Tennova Healthcare Clarksville to Vanderbilt University Medical Center for $623 million in cash.
NYSE
Community Health Systems' subsidiary has agreed to sell Crestwood Medical Center and related assets in Huntsville, Alabama, to Huntsville Hospital Health System for $450 million, with closing expected in Q2 2026.
NYSE
Community Health Systems, Inc. announced the permanent appointments of Kevin J. Hammons as Chief Executive Officer and Jason K. Johnson as Chief Financial Officer, effective immediately.
NYSE
Community Health Systems has finalized the sale of its ambulatory outreach laboratory business across 13 states to Labcorp for approximately $194 million in cash, aiming to enhance focus on core hospital services.
NYSE
Community Health Systems' subsidiaries have agreed to sell their 80% ownership in Tennova Healthcare Clarksville and related businesses to Vanderbilt University Medical Center for $600 million.
NYSE
Community Health Systems, Inc. announced a significant turnaround in its third-quarter 2025 financial results, reporting net income of $130 million compared to a net loss in the prior year, alongside updated positive annual earnings guidance.
NYSE
Community Health Systems, Inc. has entered into a consultancy agreement with its retiring CEO, Tim L. Hingtgen, for a one-year term starting October 1, 2025.
NYSE
Community Health Systems announced the appointment of Kevin J. Hammons as Interim CEO and Jason K. Johnson as Interim CFO, effective October 1, 2025, following the retirement of current CEO Tim L. Hingtgen.
NYSE
Community Health Systems, Inc. completed a $1.79 billion offering of 9.750% Senior Secured Notes due 2034, using proceeds to repurchase a significant portion of its 2027 Notes.
NYSE
Community Health Systems, Inc. announced an upsized offering of $1.79 billion in 9.750% Senior Secured Notes due 2034 to refinance its outstanding 5.625% Senior Secured Notes due 2027.
NYSE
Community Health Systems, Inc. announced the retirement of CEO Tim L. Hingtgen, effective September 30, 2025, with Kevin J. Hammons appointed Interim CEO and Jason K. Johnson as Interim CFO.
NYSE
Community Health Systems, Inc. announced a significant turnaround to net income in the second quarter of 2025, driven by substantial gains from divestitures and debt extinguishment, alongside updated full-year earnings guidance.
NYSE
Community Health Systems' subsidiary, CHS/Community Health Systems, Inc., has entered into a definitive agreement to sell select ambulatory outreach laboratory services assets to Laboratory Corporation of America Holdings for $195 million in cash.
NYSE
Community Health Systems, Inc. subsidiaries have completed the sale of their 80% ownership interest in Cedar Park Regional Medical Center to Ascension Health for $436 million in cash, resulting in an estimated $93 million after-tax gain.
NYSE
Community Health Systems stockholders approved the amendment and restatement of the 2009 Stock Option and Award Plan and a certificate of amendment providing for officer exculpation at the Annual Meeting held on May 13, 2025.
NYSE
Community Health Systems completed the issuance of $700 million in 10.750% senior secured notes due 2033, and amended the indenture for its 2028 notes, removing restrictive covenants.
NYSE
Community Health Systems reports strong early tender results for its 6.875% Senior Unsecured Notes due 2028, with approximately 93.32% of the notes tendered by the early deadline.
NYSE
Community Health Systems, Inc. is offering to purchase any and all of its outstanding 6.875% Senior Unsecured Notes due 2028 through a cash tender offer and related consent solicitation.
NYSE
Community Health Systems plans to issue $700 million in new senior secured notes to redeem its existing 2027 notes and cover related expenses.
NYSE
Community Health Systems, Inc. announced its first quarter 2025 results, highlighting increased same-store admissions and a reduced net loss compared to the same period last year.
NYSE
Community Health Systems has agreed to sell its 80% ownership interest in Cedar Park Regional Medical Center to Ascension Health subsidiaries for $460 million.
NYSE
Community Health Systems completes the sale of Lake Norman Regional Medical Center to Duke University Health System for $284 million, marking a significant disposition of assets.
NYSE
Community Health Systems completes the sale of ShorePoint Health facilities in Florida to Adventist Health System for $260 million.
NYSE
Community Health Systems reports a net loss for Q4 2024, but highlights strong same-store volume growth and provides 2025 earnings guidance.